Brief: Summit Therapeutics Raises $235 Mln
12/09/2024 11:32
Sept 12 (Reuters) - Summit Therapeutics Inc SMMT.O :
* SUMMIT THERAPEUTICS RAISES $235 MILLION
* SUMMIT THERAPEUTICS INC - INTENDS TO USE NET PROCEEDS TO
ADVANCE, IN PART, CLINICAL DEVELOPMENT OF IVONESCIMAB
Source text for Eikon: ID:nBw6j0FPca
Further company coverage: SMMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Summit Therapeutics rebounds after pulling stock offering
Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
Summit Therapeutics falls on launching $500 mln stock offering